Wei Wang

Mr. Wei Wang

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2020 in Sleep Medicine
Verified
Journal Article
Closed access
CLChuntian Lu
Chuntian Lu
BLBing Liao
Bing Liao
JNJing Nie Nie
Jing Nie Nie
WWWei Wang
Wei Wang
YWYafeng Wang
Yafeng Wang

10 June 2020 in Briefings in Bioinformatics
Verified
Journal Article
Closed access
PDF file
WWWei Wang
Wei Wang
QDQiuYing Dai
QiuYing Dai
FLFang Li
Fang Li
YXYI XIONG
YI XIONG
DWDong-Qing Wei
Dong-Qing Wei
The long non-coding RNAs (lncRNAs) are subject of intensive recent studies due to its association with various human diseases. It is desirable to build the artificial intelligence-based models for prediction of diseases or tissues based on the lncRNAs data, which will be useful in disease diagnosis and therapy. The accuracy and robustness of existing models based on the machine learning techniques are subject to further improvement. In this study, we propose a deep learning model, called Multi-Label Classifications with Deep Forest, termed MLCDForest, to address multi-label classification on tissue prediction for a given lncRNA, which can be regarded as an implementation of the deep forest model in multi-label classification. The MLCDForest is a sequential multi-label-grained scanning method, which distinguishes from the standard deep forest model. It is proposed to train in sequential of multi-labels with label correlation considered. A systematic comparison using the lncRNA-disease association datasets demonstrates that our method consistently shows superior performance over the state-of-the-art methods in disease prediction. Considering label correlation in the sequential multi-label-grained scanning, our model provides a powerful tool to make multi-label classification and tissue prediction based on given lncRNAs.

1 January 2019
Verified
Journal Article
Closed access
YWYafeng Wang
Yafeng Wang
HTHuan Tao
Huan Tao
RPRaheem J. Paxton
Raheem J. Paxton
JWJunfeng Wang
Junfeng Wang
sumaira mubariksumaira mubarik
sumaira mubarik
CYChuanhua Yu
Chuanhua Yu

17 July 2019 in Interdisciplinary Sciences: Computational Life Sciences
Verified
Journal Article
Closed access
PDF file
HDHao Dai
Hao Dai
WWWei Wang
Wei Wang
QXQin Xu
Qin Xu
YXYi Xiong
Yi Xiong
DWDong-Qing Wei
Dong-Qing Wei

14 October 2021 in Journal of Evidence-Based Medicine
Verified
Journal Article
Closed access
PDF file
HThuan tao
huan tao
AOAdrienne O'NEil
Adrienne O'NEil
RPRaheem J Paxton
Raheem J Paxton
WWWei Wang
Wei Wang
XDXiang Deng
Xiang Deng
JNJing Nie Nie
Jing Nie Nie

3 June 2019 in bioRxiv
Verified
Preprint
Open access
PDF file
YCYan-Yi Chu
Yan-Yi Chu
YZYufang Zhang
Yufang Zhang
WWWei Wang
Wei Wang
XWXiangeng Wang
Xiangeng Wang
XSXiao-Qi Shan
Xiao-Qi Shan
DWDong-Qing Wei
Dong-Qing Wei
Drug-target interactions play a crucial role in target-based drug discovery and exploitation. Computational prediction of DTIs has become a popular alternative strategy to the experimental methods for identification of DTIs of which are both time and resource consuming. However, the performances of the current DTIs prediction approaches suffer from a problem of low precision and high false positive rate. In this study, we aimed to develop a novel DTIs prediction method, named DTI-CDF, for improving the prediction precision based on a cascade deep forest model which integrates hybrid features, including multiple similarity-based features extracted from the heterogeneous graph, fingerprints of drugs, and evolution information of target protein sequences. In the experiments, we built five replicates of 10 fold cross-validations under three different experimental settings of data sets, namely, corresponding DTIs values of certain drugs ( S D ), targets ( S T ), or drug-target pairs ( S P ) in the training set are missed, but existed in the test set. The experimental results show that our proposed approach DTI-CDF achieved significantly higher performance than the state-of-the-art methods.